Katharine Yen
Full Professor(heuristic)
Acute Myeloid Leukemia Research · Hematology
Compare more Hematology professors.
h-index37
i10-index64
Publications126
Citations17,884
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: A phase 1 dose escalation and dose optimization study to evaluate the preliminary safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical activity profile of AUTX703 in participants with relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes (Blood)2025-11-03
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-04
Data may not be current
Find elsewhere
ORCID: 0000-0003-2054-9108